DANIEL CLAUDIO DE OLIVEIRA GOMES
Title: Doctor
Research groups: CNPq (Google Translator version)
Curriculum: https://lattes.cnpq.br/3965075540969796
Orcid: https://orcid.org/0000000206630981
Participation in projects:
Title![]() |
Starting date | Deadline (months) | Participation in the project |
---|---|---|---|
Blocking of Sestrins, PD-1 and p38 MAP kinase signalling to enhance anti-Leishmania specific immunity in humans | 01/07/2018 | 60 | Coordinator * |
REVERSING FUNCTIONAL DEFECTS OF T-CELLS TO ENHANCE ANTI-LEISHMANIA HUMAN IMMUNITY BY THE MANIPULATION OF PD-1 AND P38 MAP KINASE | 25/04/2025 | 60 | Coordinator * |
Role of cytotoxic T cells in the immunopathogenisis of cutaneous leishmanisis | 31/07/2020 | 48 | Coordinator * |
03/06/2013 | 24 | Coordinator * | |
25/12/2012 | 24 | Coordinator * |
Pages
Participants in examination boards:
Pages
Disciplines taught:
Academic term![]() |
Code | Name | Hours | Course |
---|---|---|---|---|
2021/2 | PBIO0023 | Special Topics in Biotechnology I | 30 | Master's degree in biotechnology |
2024/1 | PBIO0026 | Teaching Internship | 30 | Doctorate in biotechnology |
2024/2 | PBIO0018 | Gene and Cell Therapy | 30 | Master's degree in biotechnology |
2024/2 | PBIO0018 | Gene and Cell Therapy | 30 | Doctorate in biotechnology |
2025/1 | PBIO0027 | Teaching Internship II | 30 | Doctorate in biotechnology |
Guided Students:
Name | Title![]() |
Defense date | Role | Type |
---|---|---|---|---|
PAOLA DE OLIVEIRA LOPES | ANALYSIS OF P16, NKG2D AND MICA/B EXPRESSION IN PULMONARY INJURY OF PATIENTS WITH LETHAL COVID-19 | 12/08/2022 | Advisor * | MSc dissertation |
NATALY PESCINALLI STEGMILLER | Comparison Between the Intranasal and Intramuscular Routes for Immunization With a Staphylococcus Aureus Gross Antigen Vaccine | 30/04/2014 | Advisor * | MSc dissertation |
DIVAN HENRIQUE FERNANDES BARCELOS | EVALUATION OF Bacteriocin Leishmanicide Potential | 21/03/2018 | Advisor * | MSc dissertation |
ESTEVÃO CARLOS SILVA BARCELOS | EVALUATION OF RESVERATROL THERAPEUTIC POTENTIAL LIKE A NEW DRUG AGAINST VISCERAL LEISHMANIOSIS |
04/03/2016 | Advisor * | MSc dissertation |
EMMANOEL LOSS DIAS | Evaluation of the Role of the Tlr1 / 2 Agonist (pam3csk4) in Potentiating the Protective Effect of Laag Vaccine Administered Via Intranasal Against Visceral Murine Leishmaniasis. | 05/09/2016 | Advisor * | MSc dissertation |